Drug details

Adlarity (donepezil hydrochloride)

type of Acetylcholinesterase Inhibitors, Central

Adlarity (donepezil transdermal system) is an acetylcholinesterase inhibitor indicated for the treatment of mild, moderate, and severe dementia of the Alzheimer's type. 

The drug is often used to treat Dementia .

This drug may have the following side effects:

• vomiting,
• nausea,
• diarrhea,
• insomnia,
• muscle cramps, 
• fatigue, and 
• loss of appetite.

The following drugs are related to Adlarity, either as a replacement or used together:

• Aduhelm (aducanumab)
• Aricept (donepezil)
• Exelon (rivastigmine tartrate)
• Exelon Patch (rivastigmine transdermal system)
• Razadyne (galantamine hbr)
• Namenda (memantine hcl)
• Namenda XR (memantine hydrochloride extended release capsules)